Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

about

Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature.Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition

P2860

Q55042378-F49CE12B-E4F3-41DB-813F-3D1E78003D4C Q58699315-AAD787A5-67B5-4C12-A188-1B645476451A

P2860

Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

Item

http://www.wikidata.org/entity/Q40464058

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Circulating cell-free BRAFV600 ...... Langerhans cell histiocytosis.

@en

type

Item

label

Circulating cell-free BRAFV600 ...... Langerhans cell histiocytosis.

@en

prefLabel

Circulating cell-free BRAFV600 ...... Langerhans cell histiocytosis.

@en

P1476

Circulating cell-free BRAFV600 ...... Langerhans cell histiocytosis

@en

P2093

Alain Lefèvre-Utile

http://www.w3.org/2001/XMLSchema#string

Anne Deville

http://www.w3.org/2001/XMLSchema#string

Anne Lutun

http://www.w3.org/2001/XMLSchema#string

Anne Pagnier

http://www.w3.org/2001/XMLSchema#string

Caroline Thomas

http://www.w3.org/2001/XMLSchema#string

Catherine Paillard

http://www.w3.org/2001/XMLSchema#string

Corinne Normand

http://www.w3.org/2001/XMLSchema#string

Eric Jeziorski

http://www.w3.org/2001/XMLSchema#string

Geneviève Plat

http://www.w3.org/2001/XMLSchema#string

Hélène Lapillonne

http://www.w3.org/2001/XMLSchema#string

P2860

Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net

Recurrent BRAF mutations in Langerhans cell histiocytosis

Liquid biopsies: genotyping circulating tumor DNA

Analysis of circulating tumor DNA to monitor metastatic breast cancer

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

Cell-free nucleic acids as biomarkers in cancer patients.

Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.

How I treat Langerhans cell histiocytosis.

P304

457-467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14695

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28444728

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

about

P2860

P2860

Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921